Teva Pharmaceutical Industries Limited

(NASDAQ:TEVA)

Key Stats & Ratios

Valuation
Market Cap 34.04B
P/E 18.20
P/E (Trailing) 19.58
P/E (Forward)
Price/Sales 3.35
Price/Book 2.30
EPS 2.16
EPS Growth (ttm) -10.00%
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Mar 2008
Profitability
Operating Income 2.25B
Net Income 1.78B
Profit Margin (ttm) 17.20%
Operating Margin (ttm) 0.21%
Management Effectiveness
Return on Assets (ttm) 7.10%
Return on Equity (ttm) 11.80%
EBIT Margin (ttm) 23.30

Financials

Income Statement
Total Enterprise Value 36.90B
Revenue 10.34B
Revenue/Share 12.73
Revenue Growth (ytd) 20.80%
Annual Revenue Growth Rate (3Y) 23.96%
Annual Income Growth Rate (3Y) 13.16%
Earnings Growth (ytd) -20.00%
Gross Operating Profit (ttm) 5.98B
EBITDA 3.13B
Diluted EPS (ttm) 2.16
Balance Sheet
Total Cash 2.48B
Total Cash/Share 3.06
Total Assets 25.02B
Total Liabilities 9.94B
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.22
Current Ratio 2.00
Leverage Ratio 1.00
Book Value/Share 18.57
Cash Flow
Cash Flow 2.28B
Free Cash Flow 615.00M
Cash Flow/Share 2.81
Free Cash Flow/Share 0.76

Trading Information

Stock Price History
Beta
52Wk Change -13.10%
52Wk Change Vs. Mkt 34.00%
52Wk High 50.00
52Wk Low 35.89
10 Day Moving Average 42.08
200 Day Moving Average 44.48
Share Statistics
Average Volume 4.97M
Shares Outstanding 816.00M
Shares Float
% Held by Insiders
% Held by Institutions 64.00%
Shares Short (As of Dec 10, 2008) 43.00M
Short Ratio 5.60
Short % of Float
Dividends & Splits
Dividend Date
Dividend Yield 0.90%
Dividend Amount 0.37